Joint Formulary & PAD

Fluticasone with azelastine - Allergic rhinitis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Nasal spray
Associated Icons :
Restrictions / Comments :
Important
Reserved for use where monotherapy is inadequate. Not 1st line.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Fluticasone with azelastine
Indication :
Allergic rhinitis
Group Name :
Keywords :
Hay fever, hayfever, antihistamines, nasal sprays, allergy, seasonal allergic rhinitis, intranasal antihistamines, pollen allergy, non-sedating antihistamines, fluticasone with azelastine nasal spray
Brand Names Include :
Dymista
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Fluticasone with azelastine is used to treat.

  • No records returned.

Committee Recommendations (1)

The APC agreed Dymista (azelastine hydrochloride / fluticasone propionate) nasal spray as a treatment option for the treatment of perennial and seasonal allergic rhinitis in circumstances where:

  • fluticasone alone has demonstrated benefit
  • other corticosteroids are ineffective/not tolerated

In addition, patients requiring dose adjustments should remain on separate components.